Kyowa Kirin Announces Acquisition of Orchard Therapeutics

Kyowa Kirin and Orchard Therapeutics have entered into a definitive agreement in which Kyowa Kirin will acquire Orchard Therapeutics.

This acquisition will enable Kyowa Kirin to enhance the value of Libmeldy® and expedite the advancement of Orchard Therapeutics' next-in-line MPS programmes, as well as its early research initiatives, including genetic Crohn’s disease and frontotemporal dementia (FTD).

The collaboration between Orchard Therapeutics' innovative HSC gene therapy platform and Kyowa Kirin's capabilities and resources will facilitate the ongoing development of numerous promising biopharmaceutical candidates. These candidates have the potential to transform medical care and provide life-changing benefits, particularly in therapeutic areas such as oncology and autoimmune diseases.

Upon the completion of this acquisition, Kyowa Kirin will position itself as a global leader in the rapidly expanding field of genetic medicine. This can be achieved through the acquisition of a comprehensive portfolio that encompasses commercial, clinical, and pre-clinical haematopoietic stem cell (HSC) gene therapies. These therapies have been specifically developed to target severe diseases affecting patients and their families.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!